CardioDx sells $58mm of Series CC-1 and Series CC-2 preferred shares
CardioDx Inc. (cardiovascular diagnostics) has raised $58mm through the sale of Series CC-1 and Series CC-2 preferred and common...
START-UP's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
CardioDx sells $58mm of Series CC-1 and Series CC-2 preferred shares
CardioDx Inc. (cardiovascular diagnostics) has raised $58mm through the sale of Series CC-1 and Series CC-2 preferred and common...